latest update:
[TrialBase DB]

trial summary · NCT07040982

Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Pilot Study of Asciminib as a Maintenance Treatment Post Cellular Therapies in Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Trial record from the TrialBase DB dataset, status RECRUITING, condition B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, sponsored by City of Hope Medical Center. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07040982phase PHASE1enrollment 30start 2026-12-17

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

This phase I trial tests the safety, side effects and best dose of asciminib as maintenance treatment for adults with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL) who have undergone cellular therapies such as hematopoietic stem cell transplantation (HSCT) or chimeric antigen receptor (CAR) T cell therapy. Maintenance treatment is given to help keep cancer from coming back after it has disappeared following initial therapy. Asciminib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving asciminib may be safe and tolerable as maintenance treatment for adult patients with Philadelphia chromosome positive ALL who have undergone cellular therapies.

Source record: https://clinicaltrials.gov/study/NCT07040982

Facts

registry idNCT07040982
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE1
study typeINTERVENTIONAL
lead conditionB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
sponsorCity of Hope Medical Center
sponsor classOTHER
enrollment30
start date2026-12-17
primary completion2029-06-09
completion2029-06-09
results postednot reported

Conditions

  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Interventions

  • Asciminib
  • Biospecimen Collection
  • Bone Marrow Aspiration
  • Bone Marrow Biopsy
  • Echocardiography Test
  • Survey Administration

Countries

  • United States

Intervention types: DRUG, OTHER, PROCEDURE

Work with this record